Taiga Biotechnologies was founded to develop novel approaches to treat hematological diseases, including cancers, immunodeficiencies and autoimmune conditions. Our three-pronged approach combines novel breakthroughs in cellular, biologic and small molecule approaches to treat and manage these diseases.
Welcome to Taiga Biotechnologies.
August 7, 2008: Taiga Biotechnologies, Inc. received its first small business innovation research grant from the Department of Health and Human Services, National Institute of Allergy and Infectious Disease. The grant will be used to further develop the proprietary technology to rapidly generate human therapeutic antibodies against influenza. Read the